title: Mineral trioxide aggregate as pulp dressing agent in pulpotomy treatment of primary molars: 42-month clinical study.
abstract: OBJECTIVE
  To evaluate the long-term clinical and radiographical results of using gray mineral trioxide aggregate (MTA) in pulpotomy treatments in primary molars.
  
  
  METHODS
  A total of 69 primary molars were treated with pulpotomy procedures using MTA and follow-up every 6 months up to 42 months.
  
  
  RESULTS
  Clinical success was 100% as none of the molars showed clinical pathologic signs; radiographical success was 98.5% as one case of internal resorption was recorded. Reparative dentin deposition was found as stenosis of the pulp canals in 84% of the cases 42 months after treatment and as dentin bridge formation in 83% of the cases 42 months after treatment. Moreover, 11 permanent successors erupted at their normal exfoliation time without pathology after pulpotomy treatment with gray MTA of the primary molars.
authors.affiliation: Department of Prevention, Pediatric Dentistry and Orthodontics, Faculty of Dentistry, Complutense University of Madrid, Avda. Complutense sn, Ciudad Universitaria, 28040 Madrid, Spain. myriammaroto@yahoo.com
authors.forename: Myriam
authors.initials: M
authors.lastname: Maroto
authors.forename: Elena
authors.initials: E
authors.lastname: Barbería
authors.forename: Vicente
authors.initials: V
authors.lastname: Vera
authors.forename: Franklin
authors.initials: F
authors.lastname: García-Godoy
mesh_terms: D017607:Aluminum Compounds / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use*; D003251:Constriction, Pathologic / Q000473:pathology; D003782:Dental Pulp / Q000000981:diagnostic imaging / Q000187:drug effects*; D003786:Dental Pulp Cavity / Q000000981:diagnostic imaging / Q000187:drug effects; D003804:Dentin / Q000000981:diagnostic imaging / Q000187:drug effects; D003809:Dentin, Secondary / Q000000981:diagnostic imaging / Q000187:drug effects; D003810:Dentinogenesis / Q000187:drug effects; D004338:Drug Combinations; D005500:Follow-Up Studies; D006801:Humans; D008963:Molar / Q000473:pathology*; D010087:Oxides / Q000627:therapeutic use*; D011672:Pulpotomy / Q000379:methods*; D011859:Radiography; D012387:Root Canal Filling Materials / Q000627:therapeutic use*; D017640:Silicates / Q000627:therapeutic use*; D014078:Tooth Eruption / Q000502:physiology; D014080:Tooth Exfoliation / Q000503:physiopathology; D014091:Tooth Resorption / Q000209:etiology; D014094:Tooth, Deciduous / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D017607:Aluminum Compounds; D017610:Calcium Compounds; D004338:Drug Combinations; D010087:Oxides; D012387:Root Canal Filling Materials; D017640:Silicates; C086631:mineral trioxide aggregate